← SynDRA
ZONISAMIDE
SynDRA canonical compound SYN0001686 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CA12 |
|---|
| Mechanism of action | T-type calcium channel blocker |
|---|
| Indication | epilepsy | seizures |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- SCN1A
- CA12
- CA1
- CA7
- SCN2A
- SCN3A
- SCN11A
- SCN4A
- SCN5A
- SCN9A
- SCN10A
- SCN7A
Mechanisms of action (all sources)
- Sodium channel blocker
- T-type calcium channel blocker
- SCN1A BLOCKER
- Sodium channel alpha subunit blocker
- SCN5A BLOCKER
- SCN4A BLOCKER
- SCN7A BLOCKER
- SCN2A BLOCKER
- SCN9A BLOCKER
- SCN3A BLOCKER
- SCN11A BLOCKER
- SCN8A BLOCKER
Drug classes
- Carbonic Anhydrase Inhibitors
- Anticonvulsants
- Calcium Channel Blockers
- Calcium-Regulating Hormones and Agents
- Cardiovascular Agents
- Central Nervous System Agents
- Membrane Transport Modulators
- Anti-epileptic Agent
- P-Glycoprotein Inhibitors
ATC classes
Cross-references
Synonyms
- exceglan
- excegram
- excegran
- zonegran
- Zonisamida
- Excegran
- Zonisade
- AD-810
- CI-912
- N03AX15
- PD-110843
- Zonegran
- Zonisamide mylan
- Exceglan
- Excegram
- Tremode
- Trerief
- Zonisamidum
- Elan brand of zonisamide
- Zonisamida [Spanish]
- Zonisamide monosodium
- Zonisamidum [Latin]
- SPR_2
- AD-810N
- E-2090
- Excegran (TN)
- Zonegran (TN)
- Zonegran, Zonisamide
- Zonisamide (ZNS)
- Zonisamide (JAN/USAN/INN)
- Zonisamide [USAN:BAN:INN:JAN]
- 1,2-Benzisoxazole-3-methanesulfonamide
- 1,2-benzoxazol-3-ylmethanesulfonamide
- 1-(1,2-Benzoxazol-3-Yl)methanesulfonamide
- 1-(1,2-benzisoxazol-3-yl)methanesulfonamide
- 3-(Sulfamoylmethyl)-1,2-benzisoxazole
- 3-sulfamoylmethyl-1,2-benzisoxazole
- zonisamide (usp monograph)
Reported adverse events
- Vomiting
- Anxiety
- Ataxia
- Nausea
- Rash
- Constipation
- Agitation
- Tremor
- Nystagmus
- Diplopia
- Pruritus
- Irritability
Look up ZONISAMIDE in the interactive SynDRA portal →